2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Endocrine Tumors
Endocrine tumors are a diverse group of cancers that originate in hormone-producing glands such as the thyroid, adrenal, and pancreas. They can be benign or malignant and often present challenges in diagnosis and treatment due to their varied hormonal effects. Cancer research in this field focuses on understanding the genetic and molecular mechanisms underlying tumor development, identifying biomarkers for early detection, and developing targeted therapies to improve patient outcomes. Advances in imaging technologies and molecular profiling have enabled more precise diagnosis and personalized treatment strategies. Clinical trials investigating novel therapies, including hormone receptor-targeted drugs and immunotherapies, offer hope for improved survival rates and quality of life for patients with endocrine tumors. Ongoing collaborative efforts among researchers, clinicians, and pharmaceutical companies are essential for furthering our understanding and management of these complex cancers.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China